Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
4D Molecular Therapeutics | FDMT | Dec 23, 2024 | 5.88 | -6.81 |
51Talk Online Education Group ADR | COE | Dec 23, 2024 | 17.45 | -1.30 |
5E Advanced Materials | FEAM | Dec 23, 2024 | 0.44 | -6.13 |
60 Degrees Pharmaceuticals | SXTP | Dec 23, 2024 | 1.16 | -7.94 |
7-10 Yr Trsy Bear 3X Direxion | TYO | Dec 23, 2024 | 14.94 | +0.79 |
7-10 Yr Trsy Bull 3X Direxion | TYD | Dec 23, 2024 | 23.37 | -2.30 |
7-10 Yr Trsy Ishares | IEF | Dec 23, 2024 | 92.20 | -0.44 |
89bio | ETNB | Dec 23, 2024 | 7.99 | +0.63 |
8x8 | EGHT | Dec 23, 2024 | 2.70 | -0.74 |
908 Devices | MASS | Dec 23, 2024 | 1.90 | -7.77 |
9F ADR | JFU | Dec 23, 2024 | 1.50 | 0.00 |
A SPAC II Acquisition | ASCB | Dec 23, 2024 | 11.19 | 0.00 |
A-Mark Precious Metals | AMRK | Dec 23, 2024 | 25.35 | -1.71 |
a.k.a Brands | AKA | Dec 23, 2024 | 21.34 | -0.70 |
A.O Smith | AOS | Dec 23, 2024 | 68.56 | -0.23 |
A10 Networks | ATEN | Dec 23, 2024 | 18.51 | -0.05 |
A2Z Cust2Mate Solutions | AZ | Dec 23, 2024 | 7.15 | -0.69 |
AA Mission Acquisition | AAM | Dec 23, 2024 | 10.09 | +0.09 |
AAA - A Rated Corporate Bond Ishares | QLTA | Dec 23, 2024 | 46.71 | -0.21 |
Aadi Bioscience | AADI | Dec 23, 2024 | 2.86 | -15.63 |
AAON | AAON | Dec 23, 2024 | 123.21 | -0.74 |
AAR | AIR | Dec 23, 2024 | 59.86 | -1.17 |
Abacus Life | ABL | Dec 23, 2024 | 7.80 | +1.04 |
Abbott Laboratories | ABT | Dec 23, 2024 | 114.31 | +0.07 |
AbbVie | ABBV | Dec 23, 2024 | 178.39 | +1.60 |
AbCellera Biologics | ABCL | Dec 23, 2024 | 2.92 | +2.46 |
Abeona Therapeutics | ABEO | Dec 23, 2024 | 5.69 | -0.18 |
Abercrombie & Fitch | ANF | Dec 23, 2024 | 152.96 | -1.04 |
Aberdeen Asia-Pacificome Fund | FAX | Dec 23, 2024 | 15.26 | +0.13 |
Aberdeen Australia Equity Fund | IAF | Dec 23, 2024 | 4.27 | +1.91 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.